Newsfeeds - Spark Newswire

1 minute read

Earnings

CVRx Earnings Preview

October 31, 1:42 PM

CVRx (NASDAQ:CVRX) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that CVRx will report an earnings per share (EPS) of $-0.56.

CVRX

7 minute read

This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday

By Lisa Levin

August 1, 5:27 AM

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings (CCNB).

AHG

4 minute read

Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

July 29, 1:05 PM

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders.

AMTX

1 minute read

Earnings

Preview: CVRx’s Earnings

By Benzinga Insights

July 27, 1:34 PM

CVRx (NASDAQ:CVRX) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that CVRx will report an earnings per share (EPS) of $-0.53.

CVRX

2 minute read

CVRx Receives MR-Conditional Labeling Approval For Its Barostim Heart Failure System

By Benzinga Newsdesk

May 9, 8:34 AM

CVRx, Inc. (NASDAQ:CVRX) (“CVRx”), developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has received U.S. Food and Drug Administration (FDA)

CVRX